We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

33 hedge funds and large institutions have $69.2M invested in Axcella Health Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less funds holding

Funds holding: 3833 (-5)

21% less capital invested

Capital invested by funds: $87M → $69.2M (-$17.9M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
33
Holders Change
-5
Holders Change %
-13.16%
% of All Funds
0.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
10
Reduced
2
Closed
8
Calls
$85K
Puts
Net Calls
+$85K
Net Calls Change
-$270K
Name Holding Trade Value Shares
Change
Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$38.3M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$16M +$168K +3,422 +1%
HP
3
Harbourvest Partners
Massachusetts
$8.89M
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.56M +$19.7K +401 +1%
AG
5
Artal Group
Luxembourg
$1.45M
BlackRock
6
BlackRock
New York
$606K +$3.98K +81 +0.7%
BCM
7
Bridgeway Capital Management
Texas
$508K
Geode Capital Management
8
Geode Capital Management
Massachusetts
$427K +$127K +2,588 +44%
ZIM
9
Zacks Investment Management
Illinois
$240K
Edgewood Management
10
Edgewood Management
Connecticut
$203K
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$185K
State Street
12
State Street
Massachusetts
$157K
PPW
13
Pinnacle Private Wealth
Massachusetts
$125K +$63K +1,280 +108%
Renaissance Technologies
14
Renaissance Technologies
New York
$113K +$13.4K +272 +14%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$89K
Northern Trust
16
Northern Trust
Illinois
$68K
CCB
17
Cutter & Co Brokerage
Missouri
$40K
Charles Schwab
18
Charles Schwab
California
$38K +$35.9K +730 New
TRCT
19
Tower Research Capital (TRC)
New York
$35K +$29.9K +607 +809%
Citadel Advisors
20
Citadel Advisors
Florida
$26K +$25.1K +511 New
TC
21
TownSquare Capital
Utah
$24K
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$24K +$23K +468 New
HighTower Advisors
23
HighTower Advisors
Illinois
$22K +$1.97K +40 +10%
UBS Group
24
UBS Group
Switzerland
$11K +$4.77K +97 +78%
CAPTRUST Financial Advisors
25
CAPTRUST Financial Advisors
North Carolina
$8K

AXLA Hedge Fund Activity: Q2 2022 in Review

33 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2022, worth a combined $69.2M — down 21% from $87M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AXLA and 3 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 10 added.

The largest buyer was Fidelity Investments, adding an estimated $168K. The largest seller was Millennium Management, exiting entirely with an estimated $102K sold.

  • 33 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2022, down from 38 in Q1 2022.
  • Funds reported $69.2M of Axcella Health Inc. Common Stock stock for Q2 2022, down 21% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q2 2022 and 8 closed out, a net change of -5 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q2 2022 was Fidelity Investments, an estimated $168K added.
  • The largest Axcella Health Inc. Common Stock seller in Q2 2022 was Millennium Management, an estimated $102K sold.

Based on aggregated 13F filings for Q2 2022.